CKC-20550-87189
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 021 / MA
- Registered
- 2022-01-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Pfizer-BioNTech
-
2021-04-29
Dose 2 — Pfizer-BioNTech
-
2021-12-03
Dose 3 — Moderna
-
2022-01-06
Registered in v-safe
-
2022-01-06
Survey response — day 28, dose 3MedDRA: Fatigue, Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fatigue, sore throat, headache and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Pfizer-BioNTech | No |
| 2 | 2021-04-29 | Pfizer-BioNTech | No |
| 3 | 2021-12-03 | Moderna | No |
Free text
Release 10 — day 28, dose 3
Symptoms: Fatigue, sore throat, headache and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release